Expression and Purification of Recombinant Human Type III Collagen using the N‐terminal Transdermal Peptide in Pichia pastoris
Current Protocols · 2025
DOI: 10.1002/cpz1.70265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols, 2025. Verfasst von Yu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Medical Engineering, Anhui University, Hefei, China. Hauptthemen laut MEDLINE: Collagen Type III, Saccharomycetales, Recombinant Fusion Proteins, Pichia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
To establish a standardized technical framework for large‐scale production of recombinant collagen, we have employed Pichia pastoris GS115 as a host expression system and optimized the fermentation and purification processes for a transdermal peptide–type III collagen fusion protein (transdermal peptide–hCOL3A) at the 15‐L bioreactor scale. A recombinant vector encoding the fusion gene was constructed through codon optimization and transformed into the GS115 strain. The seed culture was prepared via shake‐flask cultivation in BMGY medium. High‐cell‐density fed‐batch fermentation was conducted in a 15‐L fermenter with an inoculum size ranging from 3% to 10%, achieving a final recombinant protein yield of 1.9 g/L. In the downstream purification, optimization of membrane‐based concentration parameters and the incorporation of strong cation‐exchange chromatography using an SP column enhanced the recovery rate of the target protein to 68%. Gel‐filtration analysis demonstrated that transdermal peptide–hCOL3A exists as a trimer, and a CCK‐8 assay revealed that it promotes proliferation of HaCaT cells in vitro , indicating biological functionality. This work successfully establishes a robust and scalable collagen production process suitable for pilot‐scale manufacturing and provides a solid technical foundation for future industrial‐scale translation. © 2025 Wiley Periodicals LLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Medical Engineering, Anhui University, Hefei, China.
- These authors contributed equally to this work.
- Anhui Zhongsheng Anlan Health Industry, Hefei, China.
ORCID-Profile: Jingjun Hong
Zitieren
APA
Wang, Y., Feng, Y., Tan, W., Liu, Y., Ji, L., & Hong, J. (2025). Expression and Purification of Recombinant Human Type III Collagen using the N‐terminal Transdermal Peptide in Pichia pastoris. Current Protocols. https://doi.org/10.1002/cpz1.70265
Vancouver
Wang Y, Feng Y, Tan W, Liu Y, Ji L, Hong J. Expression and Purification of Recombinant Human Type III Collagen using the N‐terminal Transdermal Peptide in Pichia pastoris. Current Protocols. 2025. doi:10.1002/cpz1.70265
BibTeX
@article{Wang2025,
author = {Wang, Yu and Feng, Ya and Tan, Wansen and Liu, Yue and Ji, Lei and Hong, Jingjun},
title = {Expression and Purification of Recombinant Human Type III Collagen using the N‐terminal Transdermal Peptide in Pichia pastoris},
journal = {Current Protocols},
year = {2025},
doi = {10.1002/cpz1.70265}
}
EUVIMED